Leaflet NITROXOLIN-MIP 250mg capsules

Product code:
W59990001
Quantity:
10
Indicated for:
bacterial infections
Route of administration:
oral
Substance:
nitroxoline (antibacterial antibiotic)
ATC
J01XX07 — Antiinfectives for systemic use | Other antibacterials

Precautions:

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Colitis / severe diarrhea

Seek medical advice if severe or persistent diarrhea occurs.

Nitroxoline is an antibiotic used to treat urinary tract infections caused by sensitive bacteria. This medication works by inhibiting bacterial DNA synthesis, thereby preventing the multiplication of pathogenic microorganisms.

Nitroxoline is effective against a wide range of bacteria, including Escherichia coli, Proteus, and Klebsiella. It is primarily used for acute and chronic urinary tract infections, such as cystitis and pyelonephritis.

The drug is generally well-tolerated but may cause side effects such as nausea, vomiting, or allergic reactions. It is important to follow the prescribed dosage to avoid the development of bacterial resistance.

Nitroxoline is not recommended during pregnancy or breastfeeding unless the benefits outweigh the risks. Consult your doctor before use.

General data about NITROXOLIN-MIP 250mg

Substance:
nitroxoline
Date of latest medicines list:
02-10-2013
Product code:
W59990001
Concentration:
250mg
Pharmaceutical form:
capsules
Quantity:
10
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
CHEPHASAAR CHEM.-PHARM. FABRIK GMBH - GERMANIA
Holder:
MIP PHARMA GMBH - GERMANIA
Number:
13379/2020/01
Shelf life:
2 years

Pharmaceutical forms available for nitroxoline